Browse result page of TopicalPdb


Please click on the ID to see detailed information about each entry.

The total number entries retrieved from this search are
ID1009SequenceRRRRRRRRRRRLILV
LLAI
Name11R-No. 10Nature of peptide or cargoMelanogenesis inhibitory peptideAssayConfocal microscopeTissue permeabilityWhen TMR-11R was topically applied for 24 h, the signals were only observed on the surface of the skin. In contrast, 12 h later, strong signals were detected showing that TMR-11R had arrived at the skin basal layer. Moreover, 24 and 48 hours later, the signals had spread out more and were stronger in both epidermis and dermisTissue SampleSkin from the back of a brown guinea pigPUBMED ID24602570
ID1016SequenceGKKKKKKKRRRRRRRRNameR16 (arginine-terminated peptide dendrimers)Nature of peptide or cargoPeptide dendrimers are wedge-like molecules comprising an amino acid branching core that is most typically decorated with various basic amino acids (e.g. Lys, His, Arg) on their head groupsAssayFranz diffusion cellTissue permeabilityFlux (mg/cm2/h) 21.43 ± 1.32 , Q48 (mg) 856.29 ± 39.50 Drug content in skin (mg/cm2) 151 ± 4.64 Tissue SampleHuman epidermal skinPUBMED ID24134794
ID1017SequenceGKKKKKKKRRRRRRRRNameR16 (arginine-terminated peptide dendrimers)Nature of peptide or cargoPeptide dendrimers are wedge-like molecules comprising an amino acid branching core that is most typically decorated with various basic amino acids (e.g. Lys, His, Arg) on their head groupsAssayFranz diffusion cellTissue permeabilityFlux (mg/cm2/h) 23.46 ± 2.04 , Q48 (mg) 1106.03 ± 53.80 Drug content in skin (mg/cm2) 155 ± 4.85 Tissue SampleHuman epidermal skinPUBMED ID24134794
ID1018SequenceGKKKKKKKRRRRRRRRNameR16 (arginine-terminated peptide dendrimers)Nature of peptide or cargoPeptide dendrimers are wedge-like molecules comprising an amino acid branching core that is most typically decorated with various basic amino acids (e.g. Lys, His, Arg) on their head groupsAssayFranz diffusion cellTissue permeabilityFlux (mg/cm2/h) 27.16 ± 2.65, Q48 (mg) 1256.61 ± 55.70, Drug content in skin (mg/cm2) 156 ± 6.26 Tissue SampleHuman epidermal skinPUBMED ID24134794
ID1023SequenceGRKKRRQRRRPPQRKCNameTatNature of peptide or cargoCell penetrating peptideAssayVertical Franz diffusion cellTissue permeabilityTP could not pass through the skin due to the charge repulsion effect between the negative charge of the TP and the negative charge of the skinTissue SampleAbdominal skin of Sprague–Dawley ratsPUBMED ID23311648
ID1024SequenceGRKKRRQRRRPPQRKCNameTatNature of peptide or cargoCell penetrating peptideAssayVertical Franz diffusion cellTissue permeabilityCumulative amounts0.10± 0.01 µg/cm2 and fluxes 0.60 ± 0.06 µg/cm2·hTissue SampleAcceptor compartment of Franz diffusion cell/Abdominal skin of Sprague–Dawley ratsPUBMED ID23311648
ID1025SequenceGRKKRRQRRRPPQRKCNameTatNature of peptide or cargoCell penetrating peptideAssayVertical Franz diffusion cellTissue permeabilityCumulative amounts 0.31 ± 0.04 µg/cm2 and fluxes 1.86 ± 0.24 µg/cm2·hTissue SampleAbdominal skin of Sprague–Dawley ratsPUBMED ID23311648
ID1026SequenceGRKKRRQRRRPPQRKCNameTatNature of peptide or cargoCell penetrating peptideAssayVertical Franz diffusion cellTissue permeabilityCumulative amounts 1.02 ± 0.05 µg/cm2 and fluxes 6.13± 0.28 µg/cm2·hTissue SampleAcceptor compartment of Franz diffusion cell/Abdominal skin of Sprague–Dawley ratsPUBMED ID23311648
ID1027SequenceGRKKRRQRRRPPQRKCNameTatNature of peptide or cargoCell penetrating peptideAssayVertical Franz diffusion cellTissue permeabilityCumulative amounts 4.29 ± 0.40 µg/cm2 and fluxes 25.73 ± 2.40 µg/cm2·hTissue SampleAbdominal skin of Sprague–Dawley ratsPUBMED ID23311648
ID1077SequenceGRKKRRQRRRPPQRKCNameTatNature of peptide or cargoCell penetrating peptideAssayVertical Franz diffusion cell, HPLCTissue permeabilityCumulative amounts 0.20 ± 0.05 mg/cm2 and fluxes 0.20 ± 0.05 mg/cm2·hTissue SampleViable epidermis and dermis (VED) abdominal skin of Sprague Dawley (SD) ratsPUBMED ID22564052
ID1078SequenceGRKKRRQRRRPPQRKCNameTatNature of peptide or cargoCell penetrating peptideAssayVertical Franz diffusion cell, HPLCTissue permeabilityCumulative amounts 0.43 ± 0.04 mg/cm2 and fluxes 0.14 ± 0.01 mg/cm2·hTissue SampleViable epidermis and dermis (VED) abdominal skin of Sprague Dawley (SD) ratsPUBMED ID22564052
ID1079SequenceGRKKRRQRRRPPQRKCNameTatNature of peptide or cargoCell penetrating peptideAssayVertical Franz diffusion cell, HPLCTissue permeabilityCumulative amounts 0.59 ± 0.12 mg/cm2 and fluxes 0.10 ± 0.02 mg/cm2·hTissue SampleViable epidermis and dermis (VED) abdominal skin of Sprague Dawley (SD) ratsPUBMED ID22564052
ID1083SequenceRQIKIWFQNRRMKWKKNamePenetratin (PEN)Nature of peptide or cargoPenetrate through cell and nucleus membranesAssayFranz diffusion cell system, HPLC with photodiode array detectorTissue permeability2-fold higherTissue SamplePorcine ear skinPUBMED ID22306174
ID1084SequenceRQIKIWFQNRRMKWKKNamePenetratin (PEN)Nature of peptide or cargoPenetrate through cell and nucleus membranesAssayFranz diffusion cell system, HPLC with photodiode array detectorTissue permeability2.8 wt% of the initial amountTissue SamplePorcine ear skinPUBMED ID22306174
ID1085SequenceRQIKIWFQNRRMKWKKNamePenetratin (PEN)Nature of peptide or cargoPenetrate through cell and nucleus membranesAssayThe scotch tape methodTissue permeability0.35 wt% of Na-DFCTissue SampleSC skinPUBMED ID22306174
ID1086SequenceRQIKIWFQNRRMKWKKNamePenetratin (PEN)Nature of peptide or cargoPenetrate through cell and nucleus membranesAssayThe scotch tape methodTissue permeability0.72 wt% of Na-DFCTissue SampleSC skinPUBMED ID22306174
ID1087SequenceRQIKIWFQNRRMKWKKNamePenetratin (PEN)Nature of peptide or cargoPenetrate through cell and nucleus membranesAssayThe scotch tape methodTissue permeability0.3 wt% of Na-DFCTissue SampleE + D skinPUBMED ID22306174
ID1088SequenceRQIKIWFQNRRMKWKKNamePenetratin (PEN)Nature of peptide or cargoPenetrate through cell and nucleus membranesAssayThe scotch tape methodTissue permeability0.57 wt% of Na-DFCTissue SampleE + D skinPUBMED ID22306174
ID1104SequenceKWLNALLHHGLNCAK
GVLA
NameHG1Nature of peptide or cargoAntimicrobialAssayConfocal microscopy, HPLCTissue permeabilitySignificant permeability of the peptide can be seen in confocal imagesTissue SampleICR mice skinPUBMED ID21220538
ID1105SequenceACSSSPSKHCGGRRR
RRRRR
NameTD1-R8Nature of peptide or cargoMITF-siRNA inhibition of melanin synthesis and melanoma cell apoptosis.AssayLaser scanning confocal microscopyTissue permeabilitySignificant penetration of carboxyfluorescein-labeled MITF-siR can be seen in confocal images of whole epidermis and partial dermisTissue SampleHair shaved back of BALB/c micePUBMED ID21119619
ID1106SequenceACSSSPSKHCGGRRR
RRRRR
NameTD1-R8Nature of peptide or cargoMITF-siRNA inhibition of melanin synthesis and melanoma cell apoptosis.AssayReal-time PCRTissue permeabilityThe cream penetrated the mouse skin and mouse skin exhibited a 52% and 34% decrease in MITF and TYR mRNA levels, respectively (versus naive control).Tissue SampleHair shaved back of BALB/c micePUBMED ID21119619
ID1108SequenceRALARALARALRALARNameRALANature of peptide or cargoBased on a family of amphipatic peptides that exhibit improved membrane permeability belongs to a synthetic family of CPEs.AssayFranz diffusion cell, HPLCTissue permeability60% of applied doseTissue SampleStratum corneum of ear of porcinePUBMED ID20189781
ID1114SequenceFLGGLIKIVPAMICA
VTKKC
NameRanalexinNature of peptide or cargoAntimicrobialAssayFranz diffusion cellTissue permeabilityIn combination these compounds reduced viable bacteria by 2.83 ± 0.26 log10 CFUTissue SampleAbdominal skin from a 38-year-old white female donorPUBMED ID19709343
ID1115SequenceFLGGLIKIVPAMICA
VTKKC
NameRanalexinNature of peptide or cargoAntimicrobialAssayFranz diffusion cellTissue permeabilityRanalexin (100 mg l-1) reduced viable MRSA252 by 0.13 ± 0.06 log10 CFUTissue SampleAbdominal skin from a 38-year-old white female donorPUBMED ID19709343
ID1140SequenceTRWYSMKKTTMKIIP
FNRL
NameHaptideNature of peptide or cargoImprove the cell penetration and subsequent presentation of the antigen.AssayAnti-LT antibodies determination by ELISATissue permeabilitySignificant increase in antibody titer (anti-LT) in the serum of mice on topical application with HR-gp100HTissue SampleEars of BALB/c micePUBMED ID17493711
ID1188SequenceCGSGVRGDFGSLAPR
VARQL
NamePeptide 141–159 from the VP1 protein of serotype A12Nature of peptide or cargoElicits virus neutralising antibodies in mice after transcutaneous immunisationAssayELISATissue permeabilityLog10 antibody titres=2.7 after first boosterTissue SampleAbdominal skin of BALB/c micePUBMED ID15734548
ID1189SequenceCGSGVRGDFGSLAPR
VARQL
NamePeptide 141–159 from the VP1 protein of serotype A12Nature of peptide or cargoElicits virus neutralising antibodies in mice after transcutaneous immunisationAssayELISATissue permeabilityLog10 antibody titres=3.8 after second boosterTissue SampleAbdominal skin of BALB/c micePUBMED ID15734548
ID1190SequenceCGSGVRGDFGSLAPR
VARQL
NamePeptide 141–159 from the VP1 protein of serotype A12Nature of peptide or cargoElicits virus neutralising antibodies in mice after transcutaneous immunisationAssayELISATissue permeabilityLog10 antibody titres=4.5 after third boosterTissue SampleAbdominal skin of BALB/c micePUBMED ID15734548
ID1191SequenceCGSGVRGDFGSLAPR
VARQL
NamePeptide 141–159 from the VP1 protein of serotype A12Nature of peptide or cargoElicits virus neutralising antibodies in mice after transcutaneous immunisationAssayNeutralisation assayTissue permeabilityNeutralisation indices of anti-peptide antibody responses=2.5 after first boosterTissue SampleAbdominal skin of BALB/c micePUBMED ID15734548
ID1192SequenceCGSGVRGDFGSLAPR
VARQL
NamePeptide 141–159 from the VP1 protein of serotype A12Nature of peptide or cargoElicits virus neutralising antibodies in mice after transcutaneous immunisationAssayNeutralisation assayTissue permeabilityNeutralisation indices of anti-peptide antibody responses=2.1 after second boosterTissue SampleAbdominal skin of BALB/c micePUBMED ID15734548
ID1193SequenceCGSGVRGDFGSLAPR
VARQL
NamePeptide 141–159 from the VP1 protein of serotype A12Nature of peptide or cargoElicits virus neutralising antibodies in mice after transcutaneous immunisationAssayNeutralisation assayTissue permeabilityNeutralisation indices of anti-peptide antibody responses=2.7 after third boosterTissue SampleAbdominal skin of BALB/c micePUBMED ID15734548
ID1392SequencelsaydpvdypysnsfakcNameRetro-inverso HA 91-108Nature of peptide or cargoAntigenic properties with increased resistance to proteolytic activity and consequently longer persistence in vivoAssayELISATissue permeabilityRetro-inverso peptide induced high levels of serum IgG and lung IgA antibodiesTissue SampleNasal cavity of mousePUBMED ID12220890